ArticlePLoS pathogens2026
Examining the role of IgA in a persistent model of Staphylococcus aureus colonization.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of Cold Atmospheric Plasma Against Methicillin-Resistant Staphylococcus aureus Biofilms: A Systematic Review of In Vitro Studies.BioMed research international · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Staphylococcus aureus is a human-adapted pathogen that replicates by asymptomatically colonizing its host. Nasal colonization occurs in the first weeks of life and persists in about 30% of the population. Using the mouse-adapted strain WU1 to model persistent colonization, we reported earlier that inoculation of bacteria lacking Staphylococcal protein A (SpA/Δspa) or neutralization of SpA through vaccination result in the slow decolonization of animals. Secretory (S)IgA is considered a first line of defense against pathogens at mucosal surfaces. Here, we use Ighasec-/- mutant mice to evaluate the contribution of SIgA towards decolonization. We observe that WU1 burdens are reduced in colonized Ighasec-/- mice compared to C57BL/6J animals. Both C57BL/6J and Ighasec-/- mice eliminate Δspa bacteria, yet elimination occurs more rapidly in animals lacking IgA. SpA captures Fab-VH3-type antibodies, including IgA, on the bacterial cell surface. We propose that this activity promotes colonization. Yet, we also find that antibody responses to the pathogen are altered when SpA and IgA are missing. Colonized C57BL/6J mice display a low serum IgG2c/IgG1 ratio towards staphylococcal antigens. This ratio is increased in animals colonized with Δspa and is further enhanced in Ighasec-/- mice. We attribute the former to the loss of immune evasion activity in absence of SpA, and the latter to a host compensatory mechanism upon exposure to S. aureus. Importantly, the increased IgG2c/IgG1 ratio correlates with decolonization and enhanced killing of S. aureus. Similarly, we observe that decolonization induced by SpA-vaccination is accelerated in Ighasec-/- mice which display higher anti-SpA IgG2c titers as compared to C57BL/6J animals. Together, these findings suggest that S. aureus exploits SIgA in a SpA-dependent manner for colonization and in absence of IgA, serum opsonizing antibodies may promote bacterial clearance at mucosal surfaces.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.